New Stem Cell Technique Improves Genetic Alteration
Monday, March 10, 2008 - Stem Cell Research Daily
Peter Donovan

Researchers have discovered a dramatically improved method for genetically manipulating human embryonic stem cells, making it easier for scientists to study and potentially treat thousands of disorders ranging from Huntington’s disease to muscular dystrophy and diabetes.

The technique for the first time blends two existing cell-handling methods to improve cell survival rates and increase the efficiency of inserting DNA into cells.

The new approach is up to 100 times more efficient than current methods at producing human embryonic stem cells with desired genetic alterations.

“The ability to generate large quantities of cells with altered genes opens the door to new research into many devastating disorders,” said Peter Donovan, professor of biological chemistry and developmental and cell biology at the University of California, Irvine, and co-director of the Gross Stem Cell Research Center. “Not only will it allow us to study diseases more in-depth, it also could be a key step in the successful development of future stem cell therapies.”

This study appears online this week in the journal Stem Cells.

Donovan and Leslie Lock, assistant adjunct professor of biological chemistry and developmental and cell biology at UCI, previously identified proteins called growth factors that help keep cells alive.

Growth factors are like switches that tell cells how to behave, for example to stay alive, divide or remain a stem cell. Without a signal to stay alive, the cells die.

The UCI scientists – Donovan, Lock and Kristi Hohenstein, a stem cell scientist in Donovan’s lab – used those growth factors in the current study to keep cells alive, then they used a technique called nucleofection to insert DNA into the cells. Nucleofection uses electrical pulses to punch tiny holes in the outer layer of a cell through which DNA can enter the cell.

With this technique, scientists can introduce into cells DNA that makes proteins that glow green under a special light.

The green color allows them to track cell movement once the cells are transplanted into an animal model, making it easier for researchers to identify the cells during safety studies of potential stem cell therapies.

Scientists today primarily use chemicals to get DNA into cells, but that method inadvertently can kill the cells and is inefficient at transferring genetic information.

For every one genetically altered cell generated using the chemical method, the new growth factor/nucleofection method produces between 10 and 100 successfully modified cells, UCI scientists estimate.

With the publication of this study, the new method now may be used by stem cell scientists worldwide to improve the efficiency of genetically modifying human embryonic stem cells.

“Before our technique, genetic modification of human embryonic stem cells largely was inefficient,” Hohenstein said. “This is a stepping stone for bigger things to come.”

Scientists can use the technique to develop populations of cells with abnormalities that lead to disease.

They can then study those cells to learn more about the disorder and how it is caused.

Scientists also possibly could use the technique to correct the disorder in stem cells, then use the healthy cells in a treatment.

The method potentially could help treat monogenic diseases, which result from modifications in a single gene occurring in all cells of the body.

Though relatively rare, these diseases affect millions of people worldwide.

Scientists currently estimate that more 10,000 human diseases are monogenic, according to the World Health Organization.

Examples include Huntington’s disease, sickle cell anemia, cystic fibrosis and hemophilia.

April Pyle of UCLA and Jing Yi Chern of Johns Hopkins University also worked on the genetic modification study, which was funded by the National Institutes of Health.

Thank you for posting this remarkable stuff

significant bullet point for me is the fact that after years of stagnant political wrangling on the use of discarded blastocysts for essential science research, and of course the Proffessor Huang fraud in KOREA a couple of years ago, the geniuses in science, in early 2008 came up with a replicated blastocyst, and to see how quickly that process has developed to be 100 times more efficient already, means that exponential progress will continue. And that is exciting.

URL link to the lead article.......

http://www.stemcellresearchnews.com/...asp?a=1146&z=9